Benjamin P Brown - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Benjamin P Brown

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Journal of Medicinal Chemistry|February 5, 2026

Drug Repurposing: Conversion of the Peripherally Restricted HIV Protease Inhibitor Amprenavir to Potent, Selective, and CNS-Penetrant Agonists for the Cannabinoid Receptor 2Daniel H Haymer, Renn A Duncan, Alice L Rodriguez, et al.

Cancer Cell|June 25, 2021

Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivityAriella B Hanker, Benjamin P Brown, Jens Meiler, et al.

JCI Insight|August 26, 2025

Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancerAmanda B Hesterberg, Hong Yuen Wong, Jorgen Jackson, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Journal of Medicinal Chemistry|February 5, 2026

Cancer Cell|June 25, 2021

Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivityAriella B Hanker, Benjamin P Brown, Jens Meiler, et al.

JCI Insight|August 26, 2025

Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancerAmanda B Hesterberg, Hong Yuen Wong, Jorgen Jackson, et al.

Pageof 6